Published: 26 July 2017
Author(s): Otto Mayer, Jan Bruthans, Jitka Seidlerová, Petra Karnosová, Jiří Vaněk, Markéta Hronová, Julius Gelžinský, Martina Cvíčela, Peter Wohlfahrt, Renata Cífková, Jan Filipovský
We aimed to clarify the impact of metabolic syndrome (MetS) as assessed by different definitions on the cardiovascular mortality in patients with coronary heart disease (CHD).
